Baird analyst David Rodgers raised the firm’s price target on Cencora to $261 from $232 and keeps an Outperform rating on the shares. The firm said the company is doing well, citing broad-based strength across core business, including commercial COVID contributions, volume growth, strong execution, operating leverage, and moderating generics deflation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on COR:
- Cencora Schedules Fiscal Quarter Results Discussion Webcast
- Cencora raises FY24 adjusted EPS view to $13.25-$13.50 from $12.70-$13.00
- Cencora reports Q1 adjusted EPS $3.28, consensus $2.89
- Cencora price target raised to $247 from $221 at JPMorgan
- Cencora price target raised to $240 from $220 at Argus
Questions or Comments about the article? Write to editor@tipranks.com